ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,904Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 198

$708K Total Retail Price of All Prescriptions

Rank: 27 out of 198

600 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 14,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 880 796 1 1
FUROSEMIDE 654 607 2 5
HYDROCODONE-ACETAMINOPHEN 488 419 S3 3 8
AMLODIPINE BESYLATE 473 458 4 4
POTASSIUM CHLORIDE 468 407 5 9
OMEPRAZOLE 439 380 6 3
WARFARIN SODIUM 436 417 7 7
SIMVASTATIN 409 357 8 2
GABAPENTIN 368 326 9 14
CITALOPRAM HBR 361 316 10 20
METOPROLOL SUCCINATE 342 314 11 11
METOPROLOL TARTRATE 293 274 12 10
LISINOPRIL 260 243 13 6
ZOLPIDEM TARTRATE 255 226 14 22
NAMENDA 234 234 15 33
ATORVASTATIN CALCIUM 211 209 16 12
CARVEDILOL 189 187 17 24
RANITIDINE HCL 163 134 18 54
CARBIDOPA-LEVODOPA 161 150 19 71
LOSARTAN POTASSIUM 157 156 20 18
ATENOLOL 154 154 21 17
TRIAMTERENE-HCTZ 150 141 22 32
ALENDRONATE SODIUM 146 138 23 21
BYSTOLIC 141 140 24 58
TRAMADOL HCL 138 132 25 15
GLIMEPIRIDE 136 109 26 35
ALLOPURINOL 132 132 27 23
TAMSULOSIN HCL 130 116 28 27
CYMBALTA 122 100 29 48
DIOVAN 121 121 30 34
DONEPEZIL HCL 120 120 31 28
FELODIPINE ER 120 120 31 163
TERAZOSIN HCL 118 114 33 102
CLOPIDOGREL 113 96 34 42
HYDROCHLOROTHIAZIDE 111 110 35 16
METFORMIN HCL 110 91 36 13
MELOXICAM 109 101 37 30
ISOSORBIDE MONONITRATE ER 99 73 38 60
MIRTAZAPINE 99 91 38 44
FENTANYL 93 92 S2 40 73
PROPRANOLOL HCL 90 69 41 92
CRESTOR 88 66 42 26
POLYETHYLENE GLYCOL 3350 88 72 42 41
METFORMIN HCL ER 84 75 44 64
FLUOXETINE HCL 83 71 45 78
PLAVIX 82 77 46 66
ROPINIROLE HCL 80 79 47 74
DOXAZOSIN MESYLATE 79 79 48 96
SERTRALINE HCL 77 76 49 25
PRAVASTATIN SODIUM 72 72 50 19
OXYBUTYNIN CHLORIDE 70 63 51 89
FINASTERIDE 69 69 52 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 68 53 38
RAMIPRIL 68 68 53 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 66 55 90
PANTOPRAZOLE SODIUM 67 67 55 31
QUETIAPINE FUMARATE 66 66 57 76
NOVOLIN N 64 50 58 201
LOVASTATIN 64 40 58 70
KLOR-CON M10 63 63 60 125
ZETIA 62 54 61 68
TRAZODONE HCL 62 58 61 50
SYNTHROID 62 62 61 36
PREDNISONE 61 59 64 29
IPRATROPIUM BROMIDE 60 60 65 134
LABETALOL HCL 59 55 66 194
IBUPROFEN 59 16 66 124
NOVOLOG 58 46 68 107
DETROL LA 57 49 69 170
LEVOFLOXACIN 57 52 69 81
PAROXETINE HCL 54 39 71 65
LANTUS 52 49 72 46
DIGOXIN 51 51 73 43
ALBUTEROL SULFATE 51 50 73 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.